ARGENX SE is 41.4x more valuable than Maze Therapeutics, Inc. by market capitalization ($53.35 B vs $1.29 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MAZE | ARGX |
|---|---|---|
| Market cap | $1.29 B | $53.35 B |
| US-listed rank | #2448 | #306 |
| Revenue (latest FY) | $167.50M | - |
| Net income (latest FY) | -$131.12M | - |
| Net margin | -78.3% | - |
| SEC filings | 165 | 272 |
ARGENX SE is 41.4x more valuable than Maze Therapeutics, Inc. by market capitalization ($53.35 B vs $1.29 B).
Full pages: Maze Therapeutics, Inc. and ARGENX SE, or browse the full rankings.